Back
Cerus 10K Form
Buy
61
CERS
Cerus
Last Price:
1.96
Seasonality Move:
9.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | CERS/Cerus Quarterly |
| 2023-11-02 | 10Q | CERS/Cerus Quarterly |
| 2023-08-03 | 10Q | CERS/Cerus Quarterly |
| 2023-05-04 | 10Q | CERS/Cerus Quarterly |
| 2022-11-03 | 10Q | CERS/Cerus Quarterly |
| 2022-08-04 | 10Q | CERS/Cerus Quarterly |
Receive CERS News And Ratings
See the #1 stock for the next 7 days that we like better than CERS
CERS Financial Statistics
Sales & Book Value
| Annual Sales: | $156.37M |
|---|---|
| Cash Flow: | $860K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.27 |
| Price / Book: | 7.6 |
Profitability
| EPS (TTM): | -0.17000 |
|---|---|
| Net Income (TTM): | $-31.56M |
| Gross Margin: | $86.4M |
| Return on Equity: | -59.8% |
| Return on Assets: | -15.76% |
Cerus Earnings Forecast
Key Cerus Financial Ratios
- The Gross Profit Margin over the past 27 years for CERS is 55.25%.
- The Selling, General & Administrative Expenses for CERS have been equal to 48.29% of Gross Profit Margin.
- The Research & Development expenses have been 43.26% of Revenue.
- The Interest Expense is -22.37% of Operating Income.
- The Net Earning history of CERS is -23.98% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 15 years.
Cerus Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | CERS |
| CUSIP: | 157085 |
| Website: | cerus.com |
Debt
| Debt-to-Equity Ratio: | 1.72 |
|---|---|
| Current Ratio: | 2.41 |
| Quick Ratio: | 1.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |